Evidence map›Paper›PMID 31720974›Full record

ArticleJournal of the American Society for Mass Spectrometry2019

Hydrogen-Deuterium Exchange and Hydroxyl Radical Footprinting for Mapping Hydrophobic Interactions of Human Bromodomain with a Small Molecule Inhibitor.

Ke Sherry Li, Elizabeth T Schaper Bergman, Brett R Beno, Richard Y-C Huang, Ekaterina Deyanova, Guodong Chen, Michael L Gross

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Mass spectrometry footprinting reveals how kinetic stabilizers counteract transthyretin dynamics altered by pathogenic mutations.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ke Sherry LiDepartment of Chemistry, Washington University, St. Louis, MO, 63130, USA.
Elizabeth T Schaper BergmanDepartment of Chemistry, Washington University, St. Louis, MO, 63130, USA.
Brett R BenoMolecular Structure & Design, Research and Development, Bristol-Myers Squibb, Princeton, NJ, 08540, USA.
Richard Y-C HuangPharmaceutical Candidate Optimization, Research and Development, Bristol-Myers Squibb, Princeton, NJ, 08540, USA.
Ekaterina DeyanovaPharmaceutical Candidate Optimization, Research and Development, Bristol-Myers Squibb, Princeton, NJ, 08540, USA.
Guodong ChenPharmaceutical Candidate Optimization, Research and Development, Bristol-Myers Squibb, Princeton, NJ, 08540, USA.
Michael L GrossDepartment of Chemistry, Washington University, St. Louis, MO, 63130, USA. mgross@wustl.edu.ORCID http://orcid.org/0000-0003-1159-4636
Bristol-Myers Squibb (United States) · USWashington University in St. Louis · US

Funding

TrainingP41GM103422 · NIGMS · WASHINGTON UNIVERSITY · PI YARASHESKI, KEVIN E · 2012 to 2019
$12.0M
NIGMS NIH HHS P41 GM103422NIGMS NIH HHS P41GM103422
6 · The paper itself

Abstract

Mass spectrometry (MS)-based protein footprinting, a valuable structural tool in mapping protein-ligand interaction, has been extensively applied to protein-protein complexes, showing success in mapping large interfaces. Here, we utilized an integrated footprinting strategy incorporating both hydrogen-deuterium exchange (HDX) and hydroxyl radical footprinting (i.e., fast photochemical oxidation of proteins (FPOP)) for molecular-level characterization of the interaction of human bromodomain-containing protein 4 (BRD4) with a hydrophobic benzodiazepine inhibitor. HDX does not provide strong evidence for the location of the binding interface, possibly because the shielding of solvent by the small molecule is not large. Instead, HDX suggests that BRD4 appears to be stabilized by showing a modest decrease in dynamics caused by binding. In contrast, FPOP points to a critical binding region in the hydrophobic cavity, also identified by crystallography, and, therefore, exhibits higher sensitivity than HDX in mapping the interaction of BRD4 with compound 1. In the absence or under low concentrations of the radical scavenger, FPOP modifications on Met residues show significant differences that reflect the minor change in protein conformation. This problem can be avoided by using a sufficient amount of proper scavenger, as suggested by the FPOP kinetics directed by a dosimeter of the hydroxyl radical.

Indexed as

BenzodiazepinesBromodomain Containing ProteinsCell Cycle ProteinsDeuterium Exchange MeasurementHumansHydrophobic and Hydrophilic InteractionsHydroxyl RadicalModels, MolecularProtein ConformationTandem Mass SpectrometryTranscription FactorsBenzodiazepinesBRD4 protein, humanBromodomain Containing ProteinsCell Cycle ProteinsHydroxyl RadicalTranscription FactorsBenzyl (1-methyl-6-phenyl-4Hbenzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)carbamateFast photochemical oxidation of proteins (FPOP)Human bromodomain-containing protein 4 (BRD4)Hydrogen-deuterium exchangeMass spectrometryProteinSmall-molecule binding

Identifiers

PMID31720974
PMCPMC6917846
OpenAlexW2988364536

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.